Private Equity Deals & Transactions

Bono, General Catalyst invest in genetic testing company

Californian venture firm General Catalyst has led a $45M investment in genetic testing company Color Genomics, a round also supported by the singer Bono.

Nathan Williams

28 September 2016

Californian venture capital firm General Catalyst has led a $45 million Series B investment in genetic testing company Color Genomics, a round also supported by the singer Bono.

The firm and the U2 frontman are both new investors. Existing backers Susan Wagner, the co-founder of BlackRock, and venture firms 8VC, Khosla Ventures and Emerson Collective also participated.

Color Genomics, which was founded in 2015, has developed a test which analyses genes closely associated with some of the most common hereditary cancers.

-Read more by visiting Private Healthcare Investor.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Nearly there!

PODCAST: Dechert’s PE co-head on the biggest trends in the industry

Side Letter: Oakley’s multi-billion raise; LPs’ negotiating power; GP NAV delays

PE fundraising falls by more than $100bn amid investor crunch

Side Letter: Ham Lane’s $20,000 token ticket; Brookfield’s niche secondaries approach

Bono, General Catalyst invest in genetic testing company

Nearly there!

PODCAST: Dechert’s PE co-head on the biggest trends in the industry

Side Letter: Oakley’s multi-billion raise; LPs’ negotiating power; GP NAV delays

PE fundraising falls by more than $100bn amid investor crunch

Side Letter: Ham Lane’s $20,000 token ticket; Brookfield’s niche secondaries approach

Register now

Login

Sign in to your account